Search results
Found 13 matches for
The collective force of cancer research, outreach and care across the city of Oxford, translating discoveries into better care for cancer patients.
AI reveals prostate cancer is not just one disease
29 February 2024
Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer which could revolutionise how the disease is diagnosed and treated in the future.
Edward O'Neill wins Prostate Cancer UK Career Acceleration Fellowship
17 April 2023
Dr Edward O'Neill will is to join Oxford University's Nuffield Department of Surgical Sciences after securing a prestigious Prostate Cancer UK Career Acceleration Fellowship.
Study shows delaying treatment for localised prostate cancer does not increase mortality risk
13 March 2023
Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.
Prostate cancer AI diagnosis tool begins evaluation in Oxford
10 March 2023
Researchers and clinicians in Oxford have begun an evaluation of artificial intelligence (AI) software that could help pathologists diagnose prostate cancer.
Unique Clinical Imaging Dataset Released for Artificial Intelligence Research to Accelerate Diagnosis of Prostate Cancer
23 September 2022
The National Cancer Imaging Translational Accelerator (NCITA) in partnership with the ReIMAGINE Consortium have announced the release of a unique clinical imaging dataset from the Prostate MRI Imaging Study (PROMIS)).
Genetic mapping of tumours reveals how cancers grow
11 August 2022
Researchers from the University of Oxford, KTH Royal Institute of Technology, Science for Life Laboratory, and the Karolinska Institutet, Solna, Sweden, have found that individual prostate tumours contain a previously unknown range of genetic variation.
Automated assessment of pathology image quality
6 April 2022
The new Oxford-developed artificial intelligence tool PathProfiler automates the quality control of large retrospective pathology image datasets to increase their usability in downstream research.
Two Oxford immunotherapy research projects awarded funding by Prostate Cancer UK
31 August 2021
Prostate Cancer UK have invested £1.7 million into five immunotherapy projects, including two from Profs Kate Vallis, Richard Bryant and Eileen Parkes at the University of Oxford. Read about their funded work.
Oxford wins government funding to evaluate prostate cancer detection system
24 June 2021
A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University.
Potential for radiotherapy and VTP multimodality therapy for prostate cancer
21 June 2021
A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.
New prostate cancer risk tool developed
12 May 2021
A new calculator has been developed by Professors Julia Hippisley-Cox and Carol Coupland to help GPs prioritise patients at high risk of prostate cancer.